New roles of reactive astrocytes in the brain; an organizer of cerebral ischemia

Neurochem Int. 2018 Oct:119:107-114. doi: 10.1016/j.neuint.2018.01.007. Epub 2018 Feb 2.

Abstract

The brain consists of neurons and much higher number of glial cells. They communicate each other, by which they control brain functions. The brain is highly vulnerable to several insults such as ischemia, but has a self-protective and self-repairing mechanisms against these. Ischemic tolerance or preconditioning is an endogenous neuroprotective phenomenon, where a mild non-lethal ischemic episode can induce resistance to a subsequent severe ischemic injury in the brain. Because of its neuroprotective effects against cerebral ischemia or stroke, ischemic tolerance has been widely studied. However, almost all studies have been performed from the viewpoint of neurons. Glial cells are structurally in close association with synapses. Recent studies have uncovered the active roles of astrocytes in modulating synaptic connectivity, such as synapse formation, elimination and maturation, during development or pathology. However, glia-mediated ischemic tolerance and/or neuronal repairing have received only limited attention. We and others have demonstrated that glial cells, especially astrocytes, play a pivotal role in regulation of induction of ischemic tolerance as well as repairing/remodeling of neuronal networks by phagocytosis. Here, we review our current understanding of (1) glial-mediated ischemic tolerance and (2) glia-mediated repairing/remodeling of the penumbra neuronal networks, and highlight their mechanisms as well as their potential benefits, problems, and therapeutic application.

Keywords: ABCA1; Astrocytes; HIF-1α; Ischemic tolerance; P2X7 receptors; Penumbra; Phagocytosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Brain / drug effects
  • Brain / metabolism*
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Cerebral Infarction / metabolism
  • Cerebral Infarction / pathology
  • Humans
  • Ischemic Preconditioning / methods
  • Neuroprotective Agents* / pharmacology

Substances

  • Neuroprotective Agents